Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Vermont Business Times.
Press releases published on August 5, 2025

OrthoPediatrics Corp. Reports Second Quarter 2025 Financial Results and Increases Full Year 2025 Revenue Guidance
WARSAW, Ind., Aug. 05, 2025 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced its financial results for the second …

Sow Good Appoints Candy Industry Veteran Jeff Rubin to Board of Directors
IRVING, Texas, Aug. 05, 2025 (GLOBE NEWSWIRE) -- Sow Good Inc. (Nasdaq: SOWG) (“Sow Good” or “the Company”), a trailblazer in the freeze dried candy and treat industry, today announced the appointment by its board of directors (the “Board”) of Jeff Rubin …

Clover Health Reports Second Quarter 2025 Results; Delivering Strong Sustainable Growth
Second quarter 2025 Medicare Advantage membership of 106,323, up 32% year-over-year Second quarter 2025 Total revenues of $478 million, up 34% year-over-year Second quarter 2025 profitability metrics with GAAP Net loss of $11 million, Adjusted EBITDA of $ …

AvePoint to Participate in Upcoming Investor Conferences
JERSEY CITY, N.J., Aug. 05, 2025 (GLOBE NEWSWIRE) -- AvePoint (Nasdaq: AVPT), the global leader in data security, governance and resilience, today announced that members of the Company’s executive management team will present at the following investor …

ScanTech AI Announces DeMeakey Williams, Sr. as Senior Vice President of Sales, Business Development, and Investor Relations
Proven Growth Strategist Joined ScanTech AI to Help Accelerate Revenue, Expand Global Market Share, and Deepen Capital Market Engagement Atlanta, GA, Aug. 05, 2025 (GLOBE NEWSWIRE) -- ScanTech AI Systems Inc. (the "Company" or "ScanTech AI") (Nasdaq: STAI …

Flywire Reports Second Quarter 2025 Financial Results
Second Quarter Revenue Increased 27.2% Year-over-Year Second Quarter Revenue Less Ancillary Services Increased 27.7% Year-over-Year Previous Fiscal Year 2025 revenue guidance reaffirmed, aEBITDA margin guidance raised by 75 bps at midpoint BOSTON, Aug. 05, …

Noodles & Company Names Joseph D. Christina as President and CEO
Drew Madsen to Remain on Board of Directors Reschedules Earnings Call For August 13th BROOMFIELD, Colo., Aug. 05, 2025 (GLOBE NEWSWIRE) -- Noodles …

Clearway Energy, Inc. Reports Second Quarter 2025 Financial Results
Repowering program advancing with Goat Mountain commercialized for 2027 and Mt. Storm on track Sponsor-enabled growth advancing with 2025/2026 COD program now over 1.6 GW including new offer from Clearway Group to invest in 291 MW Western states storage …

Spyre Therapeutics Reports Second Quarter 2025 Financial Results and Provides Corporate Update
Reported positive interim Phase 1 results for two next-generation TL1A antibodies, demonstrating both were well-tolerated, exhibited pharmacokinetic ("PK") profiles supporting quarterly or biannual dosing, and full TL1A engagement through up to 20 weeks of …

Grocery Outlet Holding Corp. Announces Second Quarter Fiscal 2025 Financial Results
EMERYVILLE, Calif., Aug. 05, 2025 (GLOBE NEWSWIRE) -- Grocery Outlet Holding Corp. (NASDAQ: GO) ("Grocery Outlet," the "Company," "we" or "our") today announced financial results for the second quarter of fiscal 2025 ended June 28, 2025. Highlights for …

Journey Medical Corporation to Announce Second Quarter 2025 Financial Results on August 12, 2025
SCOTTSDALE, Ariz., Aug. 05, 2025 (GLOBE NEWSWIRE) -- Journey Medical Corporation (“Journey Medical” or the “Company”) (Nasdaq: DERM), a commercial-stage pharmaceutical company that primarily focuses on selling and marketing U.S. Food and Drug …

Mdxhealth Reports Preliminary Second Quarter 2025 Results, Reaches Positive Adjusted EBITDA, and Announces Acquisition of Exosome Diagnostics Business from Bio-Techne
Mdxhealth Reports Preliminary Second Quarter 2025 Results, Reaches Positive Adjusted EBITDA, and Announces Acquisition of Exosome Diagnostics Business from Bio-Techne Year-over-year Q2 revenues increased by 20% to $26.6 million Adjusted EBITDA …

Mulvihill Canadian Bank Enhanced Yield ETF Declares Monthly Distribution
TORONTO, Aug. 05, 2025 (GLOBE NEWSWIRE) -- (TSX: CBNK) Mulvihill Canadian Bank Enhanced Yield ETF has declared a monthly cash distribution in the amount of $0.058333 per unit, payable on September 5, 2025 to unitholders of record on August 29, 2025. For …

Mulvihill Enhanced Split Preferred Share ETF Declares Monthly Distribution
TORONTO, Aug. 05, 2025 (GLOBE NEWSWIRE) -- (TSX: SPFD) Mulvihill Enhanced Split Preferred Share ETF has declared a monthly cash distribution in the amount of $0.08333 per unit, payable on September 5, 2025 to unitholders of record on August 29, 2025. For …

Premium Global Income Split Corp. Declares Monthly Distribution
TORONTO, Aug. 05, 2025 (GLOBE NEWSWIRE) -- (TSX: PGIC; PGIC.PR.A) Premium Global Income Split Corp. has declared monthly distributions payable on August 29, 2025 to shareholders of record on August 15, 2025 in the following amounts per share: Share Class …

Premium Income Corporation Announces Monthly Distribution
TORONTO, Aug. 05, 2025 (GLOBE NEWSWIRE) -- (TSX: PIC.A; PIC.PR.A) Premium Income Corporation has declared monthly distributions payable on August 29, 2025 to shareholders of record on August 15, 2025 in the following amounts per share: Share Class Ticker …

Mulvihill Premium Yield Fund Declares Monthly Fund Distribution for Its ETF Class
TORONTO, Aug. 05, 2025 (GLOBE NEWSWIRE) -- (TSX: MPY) Mulvihill Premium Yield Fund has declared a monthly cash distribution for its ETF Class in the amount of $0.06400 per unit, payable on September 5, 2025 to unitholders of record on August 29, 2025. For …

Fate Therapeutics Reports New Employee Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
SAN DIEGO, Aug. 05, 2025 (GLOBE NEWSWIRE) -- Fate Therapeutics, Inc. (NASDAQ: FATE), a clinical-stage biopharmaceutical company dedicated to bringing a first-in-class pipeline of induced pluripotent stem cell (iPSC)-derived cellular immunotherapies to …

BridgeBio Reports Second Quarter 2025 Financial Results and Business Updates
- As of August 1, 2025, 3,751 unique patient prescriptions have been written by 1,074 unique prescribers, representing an accelerating launch driven by strong month over month growth in the crucial treatment naïve patient segment - $110.6 million in total …

SIGA Reports Financial Results for Three and Six Months Ended June 30, 2025
NEW YORK, Aug. 05, 2025 (GLOBE NEWSWIRE) -- Generated Product Revenues of $79 million for the Three Months Ended June 30 Awarded Additional Development Funding of $27 million under the BARDA 19C Contract during the Three Months Ended June 30 Corporate …